Keebeck Wealth Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Keebeck Wealth Management, LLC
- $725 Million
- Q2 2025
A detailed history of Keebeck Wealth Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 20,427 shares of CPRX stock, worth $415,893. This represents 0.06% of its overall portfolio holdings.
Number of Shares
20,427
Previous 9,300
119.65%
Holding current value
$415,893
Previous $225,000
96.89%
% of portfolio
0.06%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
387Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$381 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$112 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.2 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...